Cargando…
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
Histone lysine specific demethylase 1 (LSD1) has been recognized as an important modulator in post-translational process in epigenetics. Dysregulation of LSD1 has been implicated in the development of various cancers. Herein, we report the discovery of the hit compound 8a (IC(50) = 3.93 μmol/L) and...
Autores principales: | Li, Zhonghua, Ding, Lina, Li, Zhongrui, Wang, Zhizheng, Suo, Fengzhi, Shen, Dandan, Zhao, Taoqian, Sun, Xudong, Wang, Junwei, Liu, Ying, Ma, Liying, Zhao, Bing, Geng, Pengfei, Yu, Bin, Zheng, Yichao, Liu, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663923/ https://www.ncbi.nlm.nih.gov/pubmed/31384539 http://dx.doi.org/10.1016/j.apsb.2019.01.001 |
Ejemplares similares
-
Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
por: Ambrosio, Susanna, et al.
Publicado: (2018) -
The histone demethylase LSD1/KDM1A promotes the DNA damage response
por: Mosammaparast, Nima, et al.
Publicado: (2013) -
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Inhibition as a Target for Disease Modification in Myelofibrosis
por: Gill, Harinder
Publicado: (2022) -
Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors
por: Ma, Liying, et al.
Publicado: (2020) -
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
por: Amente, Stefano, et al.
Publicado: (2015)